Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1137 of 5804
-
Gene clue could lead to surgical cure for some high blood pressure patients
Knowledge-focused ENROLLING_BY_INVITATIONPrimary aldosteronism (PA) is a known but underdiagnosed cause of high blood pressure. It is estimated that more than 10% of all people with high blood pressure (HT) suffer from PA, which is often caused by aldosterone-producing adrenal cortical tumors (APAs). In a pilot study w…
Phase: NA • Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New transplant prep aims to boost survival in leukemia patients
Disease control Not yet recruitingSafety and Feasibility of a Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation in AML, MDS/AML and Higher Risk MDS
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New Botox-Like shot could loosen stiff arms in stroke survivors
Symptom relief Not yet recruitingThis is a phase III clinical study to evaluate the efficacy and safety of recombinant botulinum toxin type A(Eveotox)in adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of Eveotox compared with placebo in adult patients with …
Phase: PHASE3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Diabetes drug metformin could help heal spinal cord injuries
Disease control Not yet recruitingBackground: Spinal cord injury (SCI) is a major global health problem, with thoraco-lumbar injuries often leading to paraplegia and incomplete neurological recovery. The glial scar, resulting from astrocyte activation at the injury site, constitutes a major barrier to axon regen…
Phase: PHASE4 • Sponsor: Badr University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI could stop diabetic foot ulcers from returning
Knowledge-focused Not yet recruitingDiabetes is one of the major chronic diseases, and diabetic foot ulcer (DFU) is a significant adverse prognosis of diabetes. The recurrence of DFU after healing involves multiple risk factors, such as changes in foot loading patterns, patient compliance, family care capacity, blo…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Antibiotic shield may protect young leukemia patients from dangerous infections
Disease control Not yet recruitingThe goal of this clinical trial is To evaluate the benefit of levofloxacin prophylaxis in prolonging the median time to first febrile neutropenia in pediatric ALL patients during induction phase. It will also learn about the safety of levofloxacin during induction treatment. The…
Phase: PHASE4 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Blood test may spare elderly fallers from unnecessary brain scans
Diagnosis Not yet recruitingThe BACHUS study focuses on a population of patients aged 75 years and older who are hospitalized after recurrent falls. The objective is to evaluate the performance of an innovative, personalized biological screening strategy to detect intracranial hemorrhages, as an alternative…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Light therapy may soothe chemo mouth sores in children
Prevention Not yet recruitingOral mucositis (OM) is a frequent, debilitating complication in pediatric oncology that impairs quality of life, nutrition, hydration, and treatment adherence. This randomized, prospective, single blind trial in Mexico will evaluate photobiomodulation (PBM) versus a conventional …
Phase: NA • Sponsor: Universidad de Guanajuato • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New injection shows promise for kidney disease in early trial
Disease control Recruiting nowTo investigate the safety, efficacy, pharmacokinetics, and pharmacodynamics of SHR-2173 injection in patients with primary membranous nephropathy
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Could a histamine shot tame chronic hives?
Disease control Recruiting nowThis is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.
Sponsor: Bharat Serums and Vaccines Limited • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Fat cell therapy shows promise for stiff hands in scleroderma
Symptom relief Recruiting nowThis prospective, randomized, blinded, multicenter clinical study aims to evaluate the safety and efficacy of autologous adipose-derived regenerative cells (ADRCs) in improving hand dysfunction in patients with systemic sclerosis (SSc). The study plans to enroll 48 eligible patie…
Phase: NA • Sponsor: Cytori Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New drug ZGGS34 targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a multicenter, open-label Phase 1/2 study in participants with advanced solid tumors. The study consists of two parts: Part 1 is a dose-escalation phase to evaluate the safety and tolerability of ZGGS34 in advanced solid tumor participants; Part 2 is a cohort-expansion ph…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill could replace needles for anemia in dialysis patients
Disease control Not yet recruitingThis study is to evaluate the efficacy and safety of QLG1218(daprodustat) following a switch from erythropoiesis-stimulating agent (ESA) in Chinese HD subjects with renal anemia who are currently treated with ESA. The primary objective is to demonstrate non-inferiority of QLG1218…
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a common mineral ease teen depression? new trial investigates
Symptom relief Not yet recruitingThe purpose of this study is to investigate the role and mechanisms of selenium in depression among children and adolescents, aiming to provide new insights for understanding the pathogenesis and treatment of depression in this population.
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New shot for eczema shows promise in Mid-Stage trial
Disease control Recruiting nowThis is a multi-center, randomized, double-blind, parallel, placebo-controlled phase 2 clinical study. A total of 403 adult participants with moderate to severe AD are planned to be enrolled to evaluate efficacy, safety, PK characteristics, immunogenicity, and changes in PD chara…
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could less immunotherapy be better? new trial tests Every-6-Week dosing for tough breast cancer
Disease control Recruiting nowTriple-negative breast cancer (TNBC), defined by the lack of ER, PR and HER2 expression, is refractory to endocrine therapy and anti-HER2 agents. Chemotherapy was once the mainstay for advanced TNBC, but its limited efficacy necessitates optimized therapeutic strategies. TNBC's h…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New PET scan could replace biopsies for breast cancer patients
Diagnosis Not yet recruitingOASIS-ImmunoPET is a monocentric pilot study evaluating antibody imaging to predict response to antibody-drug conjugate (ADC), an innovative cancer targeted therapy, and potentially replace tumor biopsy. It is addressed to patients with locally advanced or metastatic breast cance…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Can a chemo drug keep sarcoma at bay? new trial aims to find out
Disease control Recruiting nowMaintenance Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can red light save your sight? new trial for severe nearsightedness
Disease control Recruiting nowThe goal of this clinical trial is to learn if LED repeated low-level red light (RLRL) therapy works to treat pathologic myopia in adults. It will also learn about the safety of LED-RLRL. The main questions it aims to answer are: Does LED-RLRL modulate choroidal microcirculation…
Phase: NA • Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Virus cocktail takes on superbugs in cystic fibrosis trial
Disease control Not yet recruitingThis is a Phase 1, open-label, multi-center pilot study evaluating the safety and microbiological activity of intravenous (IV) bacteriophage therapy in combination with standard IV antibiotics in adults with cystic fibrosis (CF) experiencing pulmonary exacerbations due to antibio…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC